Becker's Healthcare July 1, 2024
Big costs require big decisions, as illustrated by how GLP-1s are causing leaders of hospital employee health plans to rethink their coverage plans.
GLP-1s are a popular class of medications including Ozempic, Trulicity and nine others. Most are indicated for Type 2 diabetes, one (Wegovy) is approved for serious cardiovascular events, and three (Saxenda, Wegovy and Zepbound) are approved for weight loss.
Most health plans cover the diabetes medications, but weight loss indications and off-label prescribing are complicating insurance coverage.
For a four-week supply, the list prices of GLP-1s approved for weight loss range between $1,050 and $1,350. After these drugs grew in popularity in late 2022, many commercial and state health plans slowed or stopped covering...
Today's Sponsors
Today's Sponsor